You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
IntellisTM is the world's smallest implantable neurostimulator, offering 95% capacity at 9 years1, personalised programming, and unmatched MRI access*Download the brochure
SPINAL CORD STIMULATION
The Intellis™ implantable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with current SCS systems and is optimised for the increased energy demands of High Dose (HD) therapy. The lntellis™ Platform uses a tablet with wireless programming and a neurostimulator that can record patient activity around the clock. Snapshot™ reporting allows physicians to monitor a patient’s progress objectively. Additional Medtronic exclusive features – AdaptiveStim™ and SureScan™ full-body MRI technologies – are also part of the Intellis™ Platform.
The EvolveSM Workflow gives standardised guidance on how to use HD and Low Dose (LD) for patients with chronic back and leg pain. The FocusSM Workflow gives guidance on how to apply Peripheral Nerve Stimulation (PNS) for patients with chronic back pain.
“Subjective outcomes, such as VAS and ODI are helpful - but not enough. We need more objective data to help us see what is truly happening and changing in the life of a patient who is receiving Spinal Cord Stimulation. It can then help us see them getting better, and help us show them that they are getting better”.
Prof. Maarten Moens, Belgium
Under specific conditions. Requires SureScan™ MRI implantable neurostimulator and leads. Refer to product labelling for full list of conditions.
Economic modelling (from a Danish national healthcare perspective) based on costs avoided from less frequent device replacements and associated reduction in procedure-related adverse events with 1 Intellis (RC) implant and 1 replacement surgery2; costs (reported in Danish Kroner and converted to 2020 Euros) are mean cost/patient1; considers battery longevity of 9 years for an Intellis™ SCS device3, and Medtronic’s real-world SCS data for PC battery longevity4 and frequency of procedure-related adverse event management5.
R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT Report
Holm A et al. Spinal cord stimulation for chronic back and leg pain in Denmark: A cost comparison of rechargeable and non-rechargeable devices. Value in Health. 2020;23: SUPPLEMENT 2, S577.
Data on File R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT report 11-JUL-2016.
Tinsley J et al. Regional Anesthesia and Pain Medicine, 2019;44: A174.
Brinzeu A et al. 2019 Eur. J. Pain 23 1031–44.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.